Literature DB >> 23846842

Gliopreventive effects of guanosine against glucose deprivation in vitro.

André Quincozes-Santos1, Larissa Daniele Bobermin, Débora Guerini de Souza, Bruna Bellaver, Carlos-Alberto Gonçalves, Diogo Onofre Souza.   

Abstract

Guanosine, a guanine-based purine, is recognized as an extracellular signaling molecule that is released from astrocytes and confers neuroprotective effects in several in vivo and in vitro studies. Astrocytes regulate glucose metabolism, glutamate transport, and defense mechanism against oxidative stress. C6 astroglial cells are widely used as an astrocyte-like cell line to study the astrocytic function and signaling pathways. Our previous studies showed that guanosine modulates the glutamate uptake activity, thus avoiding glutamatergic excitotoxicity and protecting neural cells. The goal of this study was to determine the gliopreventive effects of guanosine against glucose deprivation in vitro in cultured C6 cells. Glucose deprivation induced cytotoxicity, an increase in reactive oxygen and nitrogen species (ROS/RNS) levels and lipid peroxidation as well as affected the metabolism of glutamate, which may impair important astrocytic functions. Guanosine prevented glucose deprivation-induced toxicity in C6 cells by modulating oxidative and nitrosative stress and glial responses, such as the glutamate uptake, the glutamine synthetase activity, and the glutathione levels. Glucose deprivation decreased the level of EAAC1, the main glutamate transporter present in C6 cells. Guanosine also prevented this effect, most likely through PKC, PI3K, p38 MAPK, and ERK signaling pathways. Taken together, these results show that guanosine may represent an important mechanism for protection of glial cells against glucose deprivation. Additionally, this study contributes to a more thorough understanding of the glial- and redox-related protective properties of guanosine in astroglial cells.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23846842      PMCID: PMC3889382          DOI: 10.1007/s11302-013-9377-0

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  111 in total

1.  Evidence that Akt mediates platelet-derived growth factor-dependent increases in activity and surface expression of the neuronal glutamate transporter, EAAC1.

Authors:  Elizabeth Krizman-Genda; Marco I González; Olga Zelenaia; Michael B Robinson
Journal:  Neuropharmacology       Date:  2005-09-21       Impact factor: 5.250

2.  Guanosine produces an antidepressant-like effect through the modulation of NMDA receptors, nitric oxide-cGMP and PI3K/mTOR pathways.

Authors:  Luis E B Bettio; Mauricio P Cunha; Josiane Budni; Francis L Pazini; Ágatha Oliveira; André R Colla; Ana Lúcia S Rodrigues
Journal:  Behav Brain Res       Date:  2012-06-26       Impact factor: 3.332

3.  Regulation of specific functions of glial cells in somatic hybrids. I. Control of S100 protein.

Authors:  P Benda; R L Davidson
Journal:  J Cell Physiol       Date:  1971-10       Impact factor: 6.384

4.  S100 beta stimulates inducible nitric oxide synthase activity and mRNA levels in rat cortical astrocytes.

Authors:  J Hu; F Castets; J L Guevara; L J Van Eldik
Journal:  J Biol Chem       Date:  1996-02-02       Impact factor: 5.157

Review 5.  Resveratrol modulates astroglial functions: neuroprotective hypothesis.

Authors:  André Quincozes-Santos; Carmem Gottfried
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

6.  Effect of resveratrol on gliotransmitter levels and p38 activities in cultured astrocytes.

Authors:  Hao Zhou; Qing Chen; Dan Li Kong; Jiang Guo; Qian Wang; Shou Yi Yu
Journal:  Neurochem Res       Date:  2010-09-15       Impact factor: 3.996

Review 7.  Metabolism and functions of glutathione in brain.

Authors:  R Dringen
Journal:  Prog Neurobiol       Date:  2000-12       Impact factor: 11.685

8.  Oxygen-glucose deprivation decreases glutathione levels and glutamate uptake in rat hippocampal slices.

Authors:  Karina Brongholi; Daniela G Souza; Afonso C D Bainy; Alcir L Dafre; Carla I Tasca
Journal:  Brain Res       Date:  2006-03-10       Impact factor: 3.252

9.  Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization.

Authors:  L Pellerin; P J Magistretti
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-25       Impact factor: 11.205

10.  Guanosine stimulates neurite outgrowth in PC12 cells via activation of heme oxygenase and cyclic GMP.

Authors:  Christian Bau; Pamela J Middlemiss; Shaun Hindley; Shucui Jiang; Renata Ciccarelli; Francesco Caciagli; Patrizia Diiorio; Eva S Werstiuk; Michel P Rathbone
Journal:  Purinergic Signal       Date:  2005-03-07       Impact factor: 3.765

View more
  18 in total

1.  Guanosine Protects Against Cortical Focal Ischemia. Involvement of Inflammatory Response.

Authors:  Gisele Hansel; André Comiran Tonon; Felipe Lhywinskh Guella; Letícia Ferreira Pettenuzzo; Thiago Duarte; Marta Maria Medeiros Frescura Duarte; Jean Pierre Oses; Matilde Achaval; Diogo Onofre Souza
Journal:  Mol Neurobiol       Date:  2014-11-14       Impact factor: 5.590

2.  Anti-aging effects of guanosine in glial cells.

Authors:  Débora Guerini Souza; Bruna Bellaver; Larissa Daniele Bobermin; Diogo Onofre Souza; André Quincozes-Santos
Journal:  Purinergic Signal       Date:  2016-09-01       Impact factor: 3.765

Review 3.  Neuroprotective Effects of Guanosine in Ischemic Stroke-Small Steps towards Effective Therapy.

Authors:  Karol Chojnowski; Mikolaj Opielka; Wojciech Nazar; Przemyslaw Kowianski; Ryszard T Smolenski
Journal:  Int J Mol Sci       Date:  2021-06-27       Impact factor: 5.923

4.  Guanosine and GMP increase the number of granular cerebellar neurons in culture: dependence on adenosine A2A and ionotropic glutamate receptors.

Authors:  Helena Decker; Tetsade C B Piermartiri; Cláudia B Nedel; Luciana F Romão; Sheila S Francisco; Tharine Dal-Cim; Carina R Boeck; Vivaldo Moura-Neto; Carla I Tasca
Journal:  Purinergic Signal       Date:  2019-09-02       Impact factor: 3.765

5.  Guanosine inhibits LPS-induced pro-inflammatory response and oxidative stress in hippocampal astrocytes through the heme oxygenase-1 pathway.

Authors:  Bruna Bellaver; Débora Guerini Souza; Larissa Daniele Bobermin; Carlos-Alberto Gonçalves; Diogo Onofre Souza; André Quincozes-Santos
Journal:  Purinergic Signal       Date:  2015-10-02       Impact factor: 3.765

6.  Guanosine Prevents Anhedonic-Like Behavior and Impairment in Hippocampal Glutamate Transport Following Amyloid-β1-40 Administration in Mice.

Authors:  Débora Lanznaster; Josiel M Mack; Victor Coelho; Marcelo Ganzella; Roberto F Almeida; Tharine Dal-Cim; Gisele Hansel; Eduardo R Zimmer; Diogo O Souza; Rui D Prediger; Carla I Tasca
Journal:  Mol Neurobiol       Date:  2016-09-06       Impact factor: 5.590

7.  Neuroprotection Promoted by Guanosine Depends on Glutamine Synthetase and Glutamate Transporters Activity in Hippocampal Slices Subjected to Oxygen/Glucose Deprivation.

Authors:  Tharine Dal-Cim; Wagner C Martins; Daniel T Thomaz; Victor Coelho; Gabriela Godoy Poluceno; Débora Lanznaster; Samuel Vandresen-Filho; Carla I Tasca
Journal:  Neurotox Res       Date:  2016-02-08       Impact factor: 3.911

8.  2',3'-cGMP exists in vivo and comprises a 2',3'-cGMP-guanosine pathway.

Authors:  Edwin K Jackson; Zaichuan Mi; Keri Janesko-Feldman; Travis C Jackson; Patrick M Kochanek
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-02-21       Impact factor: 3.619

9.  Guanosine Anxiolytic-Like Effect Involves Adenosinergic and Glutamatergic Neurotransmitter Systems.

Authors:  Roberto Farina Almeida; Daniel Diniz Comasseto; Denise Barbosa Ramos; Gisele Hansel; Eduardo R Zimmer; Samanta Oliveira Loureiro; Marcelo Ganzella; Diogo Onofre Souza
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

Review 10.  Guanosine and its role in neuropathologies.

Authors:  Luis E B Bettio; Joana Gil-Mohapel; Ana Lúcia S Rodrigues
Journal:  Purinergic Signal       Date:  2016-03-22       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.